SCHEDULE

PART 3ELIGIBILITY CRITERIA FOR DONORS OF WHOLE BLOOD AND BLOOD COMPONENTS

However, the following deferral periods shall apply for the infections listed in the table:

Brucellosis (*)

2 years following the date of full recovery

Osteomyelitis

2 years after confirmed cured

Q fever (*)

2 years following the date of confirmed cure

Syphilis (*)

1 year following the date of confirmed cure

Toxoplasmosis (*)

6 months following the date of clinical recovery

Tuberculosis

2 years following the date of confirmed cure

Rheumatic fever

2 years following the date of cessation of symptoms, unless evidence of chronic heart disease

Fever >38°C

2 weeks following the date of cessation of symptoms

Flu-like illness

2 weeks after cessation of symptoms

Malaria (*)

 

— individuals who have lived in a malarial area within the first five years of life

3 years following return from last visit to any endemic area, provided person remains symptom free;

may be reduced to 4 months if an immunologic or molecular genomic test is negative at each donation.

— individuals with a history of malaria

3 years following cessation of treatment and absence of symptoms.

Donations may be accepted thereafter only if an immunologic or molecular genomic test is negative

— asymptomic visitors to endemic areas

6 months after leaving the endemic area unless an immunologic or molecular genomic test is negative

— individuals with a history of undiagnosed febrile illness during or within six months of a visit to an endemic area

3 years following resolution of symptoms;

may be reduced to 4 months if an immunologic or molecular test is negative

West Nile Virus (WNV) (*)

28 days after leaving an area with ongoing transmission of WNV to humans